Both Intec Pharma Ltd. (NASDAQ:NTEC) and Intrexon Corporation (NASDAQ:XON) are each other’s competitor in the Biotechnology industry. Thus the compare of their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation.
Table 1 demonstrates Intec Pharma Ltd. and Intrexon Corporation’s top-line revenue, earnings per share and valuation.
Table 2 shows us the return on equity, net margins and return on assets of both companies.
Institutional and Insider Ownership
Intec Pharma Ltd. and Intrexon Corporation has shares owned by institutional investors as follows: 39.64% and 86.7%. Insiders owned 11.81% of Intec Pharma Ltd. shares. Insiders Comparatively, owned 0.6% of Intrexon Corporation shares.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Intec Pharma Ltd. has 9.02% stronger performance while Intrexon Corporation has -36.7% weaker performance.